Sanigen Co., Ltd. (188260) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Sanigen Co., Ltd. (188260:KRX), powered by AI.

Current Price
₩1,707
P/E Ratio
-1.8
Market Cap
12.3B
Sector
Healthcare
What is the Sanigen Co., Ltd. stock price forecast?

Sanigen Co., Ltd. is currently trading at ₩1,707. View real-time AI analysis on Alpha Lenz.

What is Sanigen Co., Ltd. insider trading activity?

View the latest insider trading data for Sanigen Co., Ltd. on Alpha Lenz.

What is Sanigen Co., Ltd.'s P/E ratio?

Sanigen Co., Ltd.'s P/E ratio is -1.8.

Sanigen Co., Ltd.

₩1.71K
KRX188260
Ask about Sanigen Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Sanigen Co., Ltd. trades at a P/E of -1.8 (undervalued) with modest ROE of -59.3%.

Ask for details

Company Overview

Sanigen Co., Ltd. is a specialized biotechnology company known for its innovative solutions in the fields of molecular diagnostics and advanced genetic research. With a particular focus on the development of diagnostic kits and services, Sanigen aims to enhance the early detection and management of diseases through cutting-edge technologies. The company leverages its extensive expertise in next-generation sequencing and bioinformatics to offer comprehensive genomic profiling, which is crucial for personalized medicine and research. Sanigen's products and services serve various sectors, including healthcare, pharmaceuticals, and academic research, providing tools that aid in understanding genetic factors and disease mechanisms. As a key player in the biotechnology industry, Sanigen Co., Ltd. contributes significantly to advancements in medical diagnostics and personalized treatment strategies, positioning itself as a pivotal entity in the evolving landscape of healthcare and genetic research.

CEO박정웅
SectorHealthcare
IndustryBiotechnology
0

Company Statistics

(FY 2024)

Profile

Market Cap₩12.34B
Revenue₩15.43B
Shares Out7.23M
Employees0

Margins

Gross15.78%
EBITDA-29.81%
Operating-37.85%
Pre-Tax-42.44%
Net-42.49%

Valuation

P/E-1.81
P/B1.44
EV/Sales0.77
EV/EBITDA-1.83
P/FCF-2.05

Growth (CAGR)

Rev 3Yr-15.11%
Rev 5Yr-5.31%
Op Inc 3YrN/A
Op Inc 5YrN/A
Net Inc 3YrN/A
Net Inc 5YrN/A

Returns

ROA-36.28%
ROE-59.31%
ROIC-35.09%

Financial Health

Cash & Cash Equivalents₩5.53B
Net Debt₩915.54M
Debt/Equity78.23%
Interest CovN/A
Ask Alpha Chat

Frequently Asked Questions

Alpha Lenz
Singapore
CEO: Kyungtae Kim | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2025 Treasurer. All rights reserved.
Sanigen Co., Ltd. (Healthcare) Stock Forecast & Analysis ₩1,707 | Alpha Lenz